Off-label marketing: the competition for “biggest corporate fine” gets juicy

It is so important to admit when you’re wrong.  So here goes… When I wrote that Astra-Zeneca paid the biggest corporate fine in American history ($520 million) for the off-label marketing of Seroquel, an atypical antipsychotic [I wrote that here]; I was wrong. (NOTE: off-label marketing is the promotion of a drug – whether amongst patients, doctors, or other […]

Add increased risk of breast cancer to the possible “adverse effects” of psych meds

Metabolic syndromes are now being associated with doubling the risk of breast cancer. Neuroleptics (the atypicals) often cause metabolic syndromes. SSRIs have more recently been implicated as well. TUESDAY, June 30 (HealthDay News) — Women with high blood pressure, elevated glucose and other components of metabolic syndrome might be at increased risk for postmenopausal breast […]

Doctors Worry About Kids’ Use of Antipsychotic Drugs

From the Washington Post a couple of days ago: Doctor’s “worry”—ha! better late than never I guess…then again there is no sign they are looking for any alternatives besides OTHER drugs which will undoubtedly do some other horrendous thing. We need to get to the root of things. Not mask and cover symptoms which is […]

Here he is: the doctor who DID take the antipsychotic!!

You know how we always say the docs should take the drugs if they’re going to hand them out. Here you go. Meet a doc who did and he’s not singing quite the same tune as your average psychiatrist. From The New Zealand Herald: In 1993 Richard Bentall went a bit mad. He voluntarily took […]

Atypical antipsychotics: too hard a sell? Let’s hope so!!

As some of you may know the FDA is reviewing the use of Seroquel for all sorts of stuff at the bequest of AstraZeneca. I’ve covered it a bit here but many others have done a better job. Look here at Furious Seasons for good background info. Here is the latest tid-bit from the LA […]